Molecular Point of Care Test Market Nearly Triples in One Year, Due to COVID-19.

Molecular systems that can test at the point of care was always expected to be a factor in COVID-19.   Last year, when our report published, the novel coronavrius was limited in most news accounts to a disease affecting Wuhan, China, we said this: “As presented, the revenues for this segment are forecast to increase from […]

READ MORE..


COVID-19 Pandemic Accelerates Adoption of Diagnostic Testing at Point of Care

From Lab Pulse , a sister publication to Kalorama Information – www.labpulse.com Experience with COVID-19 has cast a bright light on the state of healthcare and the great need for change, which has already begun, said panelist Rahul Dhanda, co-founder and CEO of Sherlock Biosciences, a pioneer in diagnostics based on CRISPR gene editing technology. […]

READ MORE..


Science and Medicine Groups Predictions for 2021 in the Lab Instrumentation, Diagnostics and Imaging Industries

The unpredictable events of 2020 might cause one forswear all prediction-making.  Yet for Science and Medicine Group, the publishing brands we offer (Strategic Directions International, Bioinformatics, Kalorama Information, IMV, Instrument Business Outlook) are in the business of prediction-making.  Thus once again, we offer our top ten predictions for 2021 based on our market research publications: Recovery in […]

READ MORE..


For Roche, Alignment Between Tests and COVID-19 Vaccines is Key

The distribution of COVID-19 vaccines has focused testmakers on how they can continue to contribute when vaccines are released. For Roche Diagnostics, vaccines and tests and their alignment are key to 2021 growth. Roche held its session “Entitled COVID-19: The critical role of Diagnostics,” on the first day of The American Association of Clinical Chemistry, […]

READ MORE..


Lab Industry Voices, Diagnostic Innovation, and Ugly Sweater Parties: What We’ll be Watching at #2020AACC

Although virtual this year, this years meeting of the American Association for Clinical Chemistry (AACC) is probably more important than ever.  The industry is at the forefront of worldwide efforts to combat the COVID-19 disease.   In the United States, national focus is on laboratorians in an unprecedented way.  In vitro diagnostic vendors are under pressure […]

READ MORE..


COVID-19 Diagnostics Blog: Thermo Combo Test CE Marked; Roche Antibody Test Earns EUA – In Time for Vaccines; Antigen Testing A Focus

Hundreds of Tests on The Market, U.S. Labs Mostly Use Ten

As the COVID-19 crisis surfaced in the United States, molecular diagnostic manufacturers went to work with new RT-PCR testing kits.  There have been hundreds of tests on the market receiving EUAs from the Food and Drug Administration, but a survey from the Association of Molecular Pathology demonstrated that only a few are used by laboratories.  As part of its survey: https://www.amp.org/advocacy/sars-cov-2-survey/ labs were asked their top ten testing methods.   Among them: Abbott m2000, Roche cobas were the top two vendors in most labs’ top tens.

READ MORE..


Urgent Care and Its Enemies

Urgent care locations have grown over the past decade, Kalorama estimates the urgent care locations in the United States to be 9,900, growing from nearly 7,000 in 2013.  That’s spectacular growth, driven by a need for more healthcare services, improved insured populations and resistance to physician office waiting times.  Because of these undisputable positives, it’s […]

READ MORE..


Siemens Healthineers Announces COVID-19 Neutralizing Antibodies Test

Siemens Healthineers yesterday announced its SARS-CoV-2 IgG Antibody Test (sCOVG)1 has proven to measure neutralizing antibodies and has achieved CE Mark. The test is an enhanced version of the assay which became available globally this summer, including in the U.S. It demonstrates the ability to detect neutralizing antibodies and reports quantitative results measuring the amount […]

READ MORE..


Vaccines Won’t Eliminate the Need for COVID-19 Testing

Surprising effectiveness levels for COVID-19 vaccine candidates have been reported in the news lately, with Pfizer and Moderna releasing company data.   This rightly gives many hope, and also may lead to a question as to whether the PCR and immunoassay testing for the disease we are seeing in 2020 will continue much longer.  It may […]

READ MORE..


Vaccine Market Grows to 37.4 BN

In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015.  The finding was made in Kalorama Information’s report, Vaccines 2020 (https://kaloramainformation.com/product/vaccines-2020-world-market-analysis-players-trends/).  Strong continued growth in the global vaccines market is expected through 2025, specifically:  Growth at high double-digit rates.  Sales of adult vaccines are expected […]

READ MORE..